Todos os posts

Consenso | Revisão do sistema de classificação para relatórios sobre biópsias cutâneas de lesões melanocíticas

16 Jan, 2023 | 10:55h

Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus Statement – JAMA Network Open

Comentários: 

Classification system for reporting on skin biopsies of melanocytic lesions – University of California – Los Angeles Health Sciences

MPATH-Dx Version 2.0 Simplifies Classification of Melanoma – HealthDay

 

Comentário no Twitter

American and international #dermatopathologists revise Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis schema. MPATH-Dx V2.0 improves standardized diagnostic reporting and patient management of #melanoma. https://t.co/G0fluzq5fs

— JAMA Network Open (@JAMANetworkOpen) January 12, 2023

 

---

M-A | Diretrizes sobre transfusão na lesão cerebral traumática

16 Jan, 2023 | 10:54h

Transfusion Guidelines in Traumatic Brain Injury: A Systematic Review and Meta-Analysis of the Currently Available Evidence – Neurotrauma Reports

 

---

Sinopse | Diretrizes da Endocrine Society sobre hipercalcemia em doenças oncológicas

16 Jan, 2023 | 10:53h

Endocrine Society Hypercalcemia of Malignancy Guidelines – JAMA Oncology (gratuito por tempo limitado)

Artigo original: Guideline | Treatment of hypercalcemia of malignancy in adults

 

---

Revisão sistemática | Baclofeno para transtorno do uso do álcool

16 Jan, 2023 | 10:51h

Baclofen for alcohol use disorder – Cochrane Library

Resumo: Baclofen for alcohol use disorder – Cochrane Library

 

---

Estudo randomizado | Ecopipam para síndrome de Tourette

16 Jan, 2023 | 10:49h

Ecopipam for Tourette Syndrome: A Randomized Trial – Pediatrics

Comentário: Ecopipam May Reduce Tics in Children With Tourette Syndrome – Psychiatric News Alert

 

Comentário no Twitter

Ecopipam, a selective D1-like receptor antagonist, is in development for children & adolescents with Tourette syndrome. Can ecopipam achieve a clinically meaningful reduction in tics without the disadvantages of D2-like receptor antagonists? https://t.co/GXxnPsP74C #Pediatrics pic.twitter.com/14fwu4npJi

— AAP Pediatrics (@aap_peds) January 11, 2023

 

---

Estudo randomizado | Lebriquizumabe combinado com corticosteroides tópicos em adolescentes e adultos com dermatite atópica moderada a grave

16 Jan, 2023 | 10:48h

Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere) – JAMA Dermatology

 

Comentário no Twitter

Does blocking the IL-13 cytokine w/ lebrikizumab combined w/ topical therapy provide clinical benefit in atopic eczema? This study reflecting real-world use patterns suggests a benefit. https://t.co/apUvYO3Jqv

— JAMA Dermatology (@JAMADerm) January 13, 2023

 

---

Estudo randomizado | Radioterapia corpórea estereotáxica guiada por RM vs. guiada por TC para câncer de próstata

16 Jan, 2023 | 10:47h

Magnetic Resonance Imaging–Guided vs Computed Tomography–Guided Stereotactic Body Radiotherapy for Prostate Cancer: The MIRAGE Randomized Clinical Trial – JAMA Oncology

Comunicado de imprensa: MRI-guided radiotherapy produces fewer side effects and better quality of life for patients with localized prostate cancer – University of California

 

Comentário do autor no Twitter (fio – clique para saber mais)

Pleased to share the primary endpoint results of the randomized phase III MIRAGE trial evaluating whether aggressive margin reduction with MRI-guidance leads to reduced toxicity in the context of prostate SBRT, out today in @JAMAOncology https://t.co/5ZKElUR4uk (1/n)

— Amar Kishan (@AmarUKishan) January 12, 2023

 

---

M-A | Desfechos e complicações da vitrectomia pars plana para descolamento de retina tracional em pessoas com diabetes

16 Jan, 2023 | 10:45h

Outcomes and Complications of Pars Plana Vitrectomy for Tractional Retinal Detachment in People With Diabetes: A Systematic Review and Meta-analysis – JAMA Ophthalmology

Comentário: Pars Plana Vitrectomy Associated with High Retinal Reattachment, but Low Final Vision – HCP Live

 

Comentário no Twitter

Study findings suggest that pars plana vitrectomy is associated with high anatomic reattachment but limited final vision postoperatively, which may be useful for the counseling of patients with diabetic tractional retinal detachment. https://t.co/Comj3VOpUF

— JAMA Ophthalmology (@JAMAOphth) January 12, 2023

 

---

Estudo randomizado | Em pacientes submetidos a cirurgia cardíaca, alta dose de selênio intravenoso não reduziu a morbidade ou a mortalidade

16 Jan, 2023 | 10:43h

Effect of High-Dose Selenium on Postoperative Organ Dysfunction and Mortality in Cardiac Surgery Patients: The SUSTAIN CSX Randomized Clinical Trial – JAMA Surgery

 

Comentário no Twitter

In this study, high-dose sodium selenite was not effective in reducing the development of organ dysfunction and death in high-risk cardiac surgery patients. @CStoppe @CriticalCa https://t.co/H3HR1u1HhU

— JAMA Surgery (@JAMASurgery) January 12, 2023

 

---

M-A | Custos e benefícios clínicos de enhanced recovery after surgery (ERAS) na pancreatoduodenectomia

16 Jan, 2023 | 10:42h

Costs and clinical benefits of enhanced recovery after surgery (ERAS) in pancreaticoduodenectomy: an updated systematic review and meta-analysis – Journal of Cancer Research and Clinical Oncology

Conteúdos relacionados:

Guidelines for Perioperative Care for Pancreatoduodenectomy: Enhanced Recovery After Surgery (ERAS) Recommendations 2019 – World Journal of Surgery

Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines

Top 100 Most-Cited Articles on Enhanced Recovery After Surgery: A Bibliometric Analysis and Visualized Study – Frontiers in Surgery

 

---